Vascular Pharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.7 | Q2 | 66.6% | 0.990 | Q2 | 83.6% |
| 2024 | 3.5 | Q2 | 70.0% | 0.972 | Q2 | 83.5% |
| 2023 | 3.5 | Q2 | 72.6% | 0.969 | Q1 | 84.8% |
| 2022 | 4.0 | Q2 | 71.5% | 0.952 | Q1 | 85.1% |
| 2021 | 5.7 | Q1 | 84.0% | 1.308 | Q1 | 91.3% |
| 2020 | — | — | 1.479 | Q1 | 92.2% | |
| 2019 | — | — | 1.121 | Q1 | 88.0% | |
| 2018 | — | — | 1.277 | Q1 | 89.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1537-1891
ISSN
1879-3649
country
UScoverage
2002-2026